OHSU leadership on stage at AACR
Dozens of OHSU Knight Cancer Institute researchers commanded the spotlight at the American Association for Cancer Research Annual Meeting in Orlando, Florida. Lisa Coussens, Ph.D., who concluded...
Tag: new drug approval
New questions about the tradeoffs in ‘accelerated’ cancer drug studies
Cancer clinical trials that use less-reliable shortcut endpoints save relatively little time, according to an analysis of 107 cancer drugs approved for 188 indications from 2006 to 2017. Image:...
Cancer costs: Marketing and myth busting
More than half of cancer drugs approved in recent years may not be helping patients to live longer. Meanwhile, the average price of cancer drugs has been increasing by 10 percent annually for more...
Sizing up the FDA’s revolving door with industry
When reviewers with the Food and Drug Administration weigh the evidence for a drug company's experimental treatment, how many are thinking: I may someday work for that company? It's a difficult...
Cancer patient testimonials often tied to drug company money
Speakers who nominally represent cancer patients at advisory meetings on new drugs often have financial ties with the company seeking marketing approval. And those ties aren’t always disclosed,...